Did giraffe cardiovascular evolution solve the problem of heart failure with preserved ejection fraction?
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Did giraffe cardiovascular evolution solve the problem of heart failure with preserved ejection fraction? / Natterson-Horowitz, Barbara; Baccouche, Basil M; Mary, Jennifer; Shivkumar, Tejas; Bertelsen, Mads Frost; Aalkjær, Christian; Smerup, Morten H; Ajijola, Olujimi A; Hadaya, Joseph; Wang, Tobias.
In: Evolution, Medicine, and Public Health, Vol. 9, No. 1, 2021, p. 248-255.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Did giraffe cardiovascular evolution solve the problem of heart failure with preserved ejection fraction?
AU - Natterson-Horowitz, Barbara
AU - Baccouche, Basil M
AU - Mary, Jennifer
AU - Shivkumar, Tejas
AU - Bertelsen, Mads Frost
AU - Aalkjær, Christian
AU - Smerup, Morten H
AU - Ajijola, Olujimi A
AU - Hadaya, Joseph
AU - Wang, Tobias
N1 - © The Author(s) 2021. Published by Oxford University Press on behalf of the Foundation for Evolution, Medicine, and Public Health.
PY - 2021
Y1 - 2021
N2 - The evolved adaptations of other species can be a source of insight for novel biomedical innovation. Limitations of traditional animal models for the study of some pathologies are fueling efforts to find new approaches to biomedical investigation. One emerging approach recognizes the evolved adaptations in other species as possible solutions to human pathology. The giraffe heart, for example, appears resistant to pathology related to heart failure with preserved ejection fraction (HFpEF)-a leading form of hypertension-associated cardiovascular disease in humans. Here, we postulate that the physiological pressure-induced left ventricular thickening in giraffes does not result in the pathological cardiovascular changes observed in humans with hypertension. The mechanisms underlying this cardiovascular adaptation to high blood pressure in the giraffe may be a bioinspired roadmap for preventive and therapeutic strategies for human HFpEF.
AB - The evolved adaptations of other species can be a source of insight for novel biomedical innovation. Limitations of traditional animal models for the study of some pathologies are fueling efforts to find new approaches to biomedical investigation. One emerging approach recognizes the evolved adaptations in other species as possible solutions to human pathology. The giraffe heart, for example, appears resistant to pathology related to heart failure with preserved ejection fraction (HFpEF)-a leading form of hypertension-associated cardiovascular disease in humans. Here, we postulate that the physiological pressure-induced left ventricular thickening in giraffes does not result in the pathological cardiovascular changes observed in humans with hypertension. The mechanisms underlying this cardiovascular adaptation to high blood pressure in the giraffe may be a bioinspired roadmap for preventive and therapeutic strategies for human HFpEF.
U2 - 10.1093/emph/eoab016
DO - 10.1093/emph/eoab016
M3 - Journal article
C2 - 34447575
VL - 9
SP - 248
EP - 255
JO - Evolution, Medicine and Public Health
JF - Evolution, Medicine and Public Health
SN - 2050-6201
IS - 1
ER -
ID: 282946883